Completed
Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
NCT00659074
- Conditions
- Behavior, Fasting, Feeding Behavior, +1 more
- Locations
-
- Algorithme Pharma Laval, Quebec, Canada